Ignite Creation Date:
2024-05-06 @ 9:09 AM
Last Modification Date:
2024-10-26 @ 12:10 PM
Study NCT ID:
NCT02917304
Status:
COMPLETED
Last Update Posted:
2017-05-30
First Post:
2016-09-26
Brief Title:
A Study to Evaluate the Efficacy and Safety of GC3110A in Healthy Subjects Aged 65 Years and Older
Sponsor:
Green Cross Corporation
Organization:
GC Biopharma Corp
Study Overview
Official Title:
A Multicenter Open-label Single Arm Study to Evaluate the Immunological Efficacy and Safety of GC3110A Administered Intramuscularly in Healthy Subjects Aged 65 Years and Older
Status:
COMPLETED
Status Verified Date:
2017-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to evaluate immunological efficacy and safety of GC3110A among healthy adults over 65 years of age
Detailed Description:
Adults over 65 years of age will be once administered GC3110AQuadrivalent influenza vaccine
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None